Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Follistatin 344

FS-344, Activin-Binding Protein, FST344

Quick Stats
Studies 2
Trials 73
Completed NA INTERVENTIONAL NCT04307212

How Exercise Signals Health Responses

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

The purpose of this research is to determine the blood signals that promote health and well-being in response to exercise at different intensities.

Detailed Description

Most studies find a dose-response relationship between exercise participation and all-cause mortality. In contrast, physical inactivity and consequent overweight or obese status is associated with a cadre of health consequences. Frequently, comorbidities of obesity are mechanistically linked via chronic low grade inflammation stemming from increases in adiposity. Although exercise is known to combat obesity and obesity related disease states, the mechanisms of action are not fully understood. Therefore, the investigators propose the following study in an attempt to elucidate anti- and pro-inflammatory endocrine responses to exercise. Initial studies in animal models have provided evidence that exercise induces long-term anti-inflammatory effects, potentially via myokine signaling following skeletal muscle activation. Humans are an ideal study population as the investigators can prescribe multiple exercise protocols that mimic human behavior, and control exercise intensity to meet recommendations. Also, humans allow the investigators to collect larger plasma samples and therefore measure more circulating proteins of interest over multiple time-points. Finally, the investigators can select individuals that exercise at different frequencies, allowing the investigators to analyze the differences in endocrine responses to exercise over differing levels of fitness. In summary, a human model will allow for a much better understanding of the human condition.

Interventions

Name: 50% heart rate reserve (HRR) low intensity exercise
Type: OTHER
Description: Trained and untrained participants will exercise at a constant load intensity of 50% HRR (low intensity)
Name: 75% HRR moderate intensity exercise
Type: OTHER
Description: Trained and untrained participants will exercise at a constant load intensity of 75% HRR (moderate intensity)
Name: Control no exercise
Type: OTHER
Description: Trained and untrained participants will have a no exercise control day

Primary Outcomes

Measure: Change in plasma myokine concentration
TimeFrame: Pre-exercise, 0, 30, 60, 90 minutes post-exercise
Description: Blood samples collected during exercise will be analyzed for the concentration of plasma myokines including Brain Derived Neurotropic Factor (BDNF), Secreted Protein Acidic and Rich in Cysteine (SPARC), Leukemia Inhibitory Factor (LIF), Interleukin (IL) 15, IL-6, Myostatin, Irisin, Follistatin-like 1 (FSTL-1), Fibroblast Growth Factor 21 (FGF-21), IL-4, IL-7 receptor agonist (ra), IL-7, beta-aminoisobutyric acid (BAIBA), IL-1ra, Growth Differentiation Factor (GDF) 8, Insulin-Like Growth Factor-1 (IGF1).

Trial Information

NCT ID

NCT04307212

Status

Completed

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

USDA Grand Forks Human Nutrition Research Center

Last Updated

December 15, 2025

Related Peptides